News|Articles|July 24, 2026

Why Geopolitical Supply Chain Mapping Is Critical for Life Sciences

Author(s)Patrick Wohl
Listen
0:00 / 0:00

Key Takeaways

  • Geopolitical supply chain mapping identifies hidden dependencies across corridors, ports, airports, customs gateways, and carriers that can undermine continuity despite apparent supplier diversification.
  • Disruptions such as Red Sea diversions and Eastern Europe air corridor constraints can rapidly propagate globally, jeopardizing clinical trial materials, biologic samples, and cold-chain medicines.
SHOW MORE

Geopolitical instability is pushing life sciences firms to map supply chains beyond suppliers to protect trials and patient access.

Geopolitical instability is increasingly reshaping global trade and logistics networks. From regional conflicts and trade restrictions to sanctions, customs changes and transportation disruptions, life sciences organizations face growing pressure to understand and manage supply chain risk.

For the pharmaceutical and biotechnology sectors, the stakes are particularly high. Many products are time-sensitive, temperature-controlled and highly valuable. Delays can impact research programs, clinical trials, manufacturing operations and ultimately patient access to therapies.

Recent events have highlighted the limitations of traditional risk management approaches, which often focus primarily on suppliers and manufacturing locations. In reality, disruption can occur anywhere across the logistics network. As a result, geopolitical supply chain mapping is emerging as an important tool for improving visibility, strengthening resilience and maintaining continuity across increasingly complex global supply chains.

Understanding Geopolitical Risk in Life Sciences Supply Chains

Geopolitical events can affect every stage of a life sciences supply chain, often with little warning. The conflict in Eastern Europe disrupted major air freight corridors between Europe and Asia, while attacks on commercial shipping in the Red Sea forced vessels to take longer alternative routes around the Cape of Good Hope. More recently, instability in the Middle East has periodically affected air freight operations and route availability. These events have demonstrated how a disruption in one region can rapidly affect transportation networks worldwide.1

For life sciences organizations, the consequences extend far beyond freight delays. A delayed shipment may contain clinical trial materials, critical manufacturing components, biological samples or temperature-sensitive medicines. Even relatively short disruptions can have significant operational and financial implications.

The challenge is that many vulnerabilities remain hidden until something goes wrong. Organizations may have a clear understanding of direct suppliers but less visibility into the transportation routes, logistics hubs and carrier networks that support their supply chains. As global supply chains become increasingly interconnected, these dependencies can create unexpected points of risk. This is why supply chain resilience is becoming a strategic priority rather than simply an operational concern.

Mapping Supply Chain Vulnerabilities Before Disruption Occurs

To build resilience, organizations first need visibility. Geopolitical supply chain mapping goes beyond traditional supplier mapping by examining how critical materials move through the entire logistics network. This includes transportation corridors, airports, seaports, carrier networks, customs gateways, distribution centers and supporting infrastructure. The objective is to identify dependencies that could affect continuity if disrupted.

For example, an organization may believe it has diversified suppliers across multiple countries, only to discover that all suppliers rely on the same airport hub or transportation corridor. Similarly, a critical clinical trial may depend on a single route that becomes vulnerable to geopolitical restrictions or regulatory changes. By identifying these dependencies, organizations can assess potential single points of failure, better understand risk concentration and develop mitigation strategies before disruption occurs.

Importantly, supply chain mapping should not be viewed as a one-time exercise. Geopolitical conditions, regulations and transportation networks continue to evolve. Maintaining an accurate understanding of supply chain risk requires continuous monitoring and regular review.

Building Resilience Into Logistics Strategies

Resilience begins long before a disruption occurs. One of the key benefits of geopolitical supply chain mapping is that it enables organizations to incorporate risk intelligence into logistics planning. Rather than relying exclusively on preferred routes or carriers, companies can evaluate alternatives before they become necessary.

This may involve assessing multiple transportation options, qualifying additional carriers or identifying alternative routing strategies for critical shipments. While these measures may introduce additional complexity, they can significantly improve flexibility during periods of disruption.

Recent events have also highlighted the importance of balancing efficiency with resilience. For many years, supply chains were designed primarily around cost optimization and speed. Today, organizations are increasingly recognizing that the lowest-cost route may not always be the most resilient.

Scenario planning is becoming an important part of this process. By modeling the impact of events such as airspace closures, sanctions, customs disruptions or transportation capacity constraints, organizations can better understand vulnerabilities and test response strategies before they are required.

Maintaining Continuity Through Flexibility and Contingency Planning

Even the most resilient supply chains will experience disruption. What often determines success is the ability to respond quickly and effectively when circumstances change.

Recent disruptions affecting Middle East air freight networks provide a useful example. As carrier schedules changed and route availability fluctuated, organizations shipping clinical trial materials, biological samples and temperature-controlled medicines faced increased uncertainty. In response, Biocair teams continuously monitored transportation conditions, reviewed alternative carrier and routing options, coordinated temperature-controlled storage where required and worked directly with customers to minimize disruption while protecting product integrity. Maintaining the required temperature range and ensuring continuity of supply remained the primary focus throughout the disruption.

The experience reinforced an important lesson: resilience is not about predicting every event. It is about having the flexibility, visibility and expertise to adapt when disruption occurs.

For life sciences organizations, contingency planning should therefore extend beyond transportation. Consideration must also be given to customs requirements, regulatory obligations, product integrity, chain of custody and stakeholder communication. This is particularly important for advanced therapies, biologics and other high-value products where delays can have significant consequences.

Turning Supply Chain Intelligence Into Faster Decisions

Visibility is only valuable if it supports action. Advances in shipment tracking, monitoring technologies and supply chain intelligence tools have improved organizations' ability to identify emerging risks across global networks. However, the most resilient organizations combine technology with clear accountability and effective decision-making processes.

When disruption occurs, stakeholders need timely information and a clear understanding of responsibilities. Manufacturers, logistics providers, quality teams and supply chain managers must be able to collaborate quickly and confidently.

Recent geopolitical events have highlighted the value of strong partnerships. While technology can provide visibility into changing conditions, experienced logistics specialists play a critical role in assessing options, evaluating risk and helping organizations respond effectively.

The ability to convert information into informed decisions is becoming a critical capability for life sciences supply chains.

Embedding Geopolitical Resilience Into Long-Term Supply Chain Strategy

Geopolitical uncertainty is unlikely to disappear. Instead, it has become a lasting feature of the global operating environment.2

As a result, leading organizations are embedding geopolitical risk management into broader supply chain strategy. This includes diversifying supply chain dependencies, maintaining operational flexibility, investing in visibility tools and establishing processes for ongoing risk assessment.

Technology will continue to play an increasingly important role. Enhanced tracking capabilities, predictive analytics and supply chain intelligence platforms can help organizations identify potential vulnerabilities earlier and improve preparedness. However, resilience ultimately depends on more than technology alone. It requires a combination of visibility, planning, flexibility and collaboration across the supply chain ecosystem.

Conclusion

Geopolitical risks are becoming an increasingly important factor in life sciences supply chain management. As supply chains become more interconnected, organizations need greater visibility into the dependencies and vulnerabilities that may affect critical shipments. Geopolitical supply chain mapping provides a structured way to identify these risks, support mitigation planning and improve decision-making.

While disruption cannot always be prevented, proactive planning, contingency strategies and operational flexibility can significantly reduce its impact. Equally important are visibility, accountability and the ability to make informed decisions quickly when conditions change.

Ultimately, organizations that invest in understanding and managing geopolitical risk will be better positioned to protect research programs, maintain manufacturing continuity, preserve product integrity and ensure therapies reach patients when they are needed most. In today's environment, resilience is no longer simply a competitive advantage. It is an operational necessity.

Patrick Wohl is senior operations director, EMEA, at Biocair.

References

1. UNCTAD. Navigating Troubled Waters: Impact to Global Trade of Disruption of Shipping Routes in the Red Sea, Black Sea and Panama Canal. February 2024. https://unctad.org/publication/navigating-troubled-waters-impact-global-trade-disruption-shipping-routes-red-sea-black

2. World Economic Forum. Global Risks Report 2025. January 2025. https://www.weforum.org/publications/global-risks-report-2025/